These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1384994)

  • 1. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
    Banik NL
    Crit Rev Neurobiol; 1992; 6(4):257-71. PubMed ID: 1384994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain secreted by activated human lymphoid cells degrades myelin.
    Deshpande RV; Goust JM; Hogan EL; Banik NL
    J Neurosci Res; 1995 Oct; 42(2):259-65. PubMed ID: 8568927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic degradation of myelin basic protein in central nervous system lesions of monkeys with experimental allergic encephalomyelitis.
    Rauch HC; Einstein ER; Csejtey J
    Neurobiology; 1973; 3(3):195-205. PubMed ID: 4124846
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated neutral protease activity in myelin from brains of patients with multiple sclerosis.
    Sato S; Quarles RH; Brady RO; Tourtellotte WW
    Ann Neurol; 1984 Mar; 15(3):264-7. PubMed ID: 6202231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases.
    Gendelman HE; Pezeshkpour GH; Pressman NJ; Wolinsky JS; Quarles RH; Dobersen MJ; Trapp BD; Kitt CA; Aksamit A; Johnson RT
    Ann Neurol; 1985 Sep; 18(3):324-8. PubMed ID: 2413798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative role of calpain in the pathophysiology of experimental optic neuritis.
    Shields DC; Banik NL
    Exp Eye Res; 1998 Oct; 67(4):403-10. PubMed ID: 9820787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
    J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of myelin breakdown in experimental demyelination: a putative role for calpain.
    Schaecher KE; Shields DC; Banik NL
    Neurochem Res; 2001 Jun; 26(6):731-7. PubMed ID: 11519732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
    Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
    Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic enzymes in demyelination.
    Smith ME
    Prog Clin Biol Res; 1980; 39():1-10. PubMed ID: 6995990
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocytes, key cells in myelination and target in demyelinating diseases.
    Bologa L
    J Neurosci Res; 1985; 14(1):1-20. PubMed ID: 2410623
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelin-associated glycoprotein in demyelinating disorders.
    Quarles RH
    Crit Rev Neurobiol; 1989; 5(1):1-28. PubMed ID: 2475262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and suppression of inflammatory demyelination.
    Norton WT; Brosnan CF; Cammer W; Goldmuntz EA
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):225-35. PubMed ID: 2130645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.
    Calzà L; Fernandez M; Giuliani A; D'Intino G; Pirondi S; Sivilia S; Paradisi M; Desordi N; Giardino L
    Brain Res Brain Res Rev; 2005 Apr; 48(2):339-46. PubMed ID: 15850672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymic hydrolysis of myelin basic protein and other proteins in central nervous system and lymphoid tissues from normal and demyelinating rats.
    Buletza GF; Smith ME
    Biochem J; 1976 Jun; 156(3):627-33. PubMed ID: 949344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions to enzyme histochemistry of the experimental demyelination.
    Gabrielescu E
    Rev Roum Physiol; 1969; 6(1):45-54. PubMed ID: 5403633
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L.
    Banati RB; Rothe G; Valet G; Kreutzberg GW
    Glia; 1993 Feb; 7(2):183-91. PubMed ID: 8432559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.